| 2025-12-10 |
详情>>
内部人交易：
Corrales Eugenia等共交易2笔
|
| 2025-10-30 |
详情>>
股本变动：
变动后总股本22319.89万股
|
| 2025-10-30 |
详情>>
业绩披露：
2026年一季报每股收益-0.1美元,归母净利润-2140万美元,同比去年增长-1088.89%
|
| 2025-10-29 |
财报披露：
美东时间 2025-10-29 盘后发布财报
|
| 2025-10-03 |
股东大会：
将于2025-11-12召开股东大会
会议内容 ▼▲
- 1.Election of Directors
2.Ratification of the Appointment of PricewaterhouseCoopers LLP as VIAVI’s independent registered public accounting firm for fiscal year 2026
3.Approval, in a Non-Binding Advisory Vote, of the Compensation for Named Executive Officers
4.Amendment and Restatement of our 2003 Equity Incentive Plan
5.Amendment and Restatement of our Certificate of Incorporation to Include an Officer Exculpation Provision
|
| 2025-08-11 |
详情>>
业绩披露：
2023年年报每股收益0.11美元,归母净利润2550.00万美元,同比去年增长64.52%
|
| 2025-08-11 |
详情>>
业绩披露：
2025年年报每股收益0.16美元,归母净利润3480.00万美元,同比去年增长234.88%
|
| 2025-05-02 |
详情>>
业绩披露：
2025年三季报(累计)每股收益0.12美元,归母净利润2680.00万美元,同比去年增长753.66%
|
| 2025-01-31 |
详情>>
业绩披露：
2025年中报每股收益0.03美元,归母净利润730.00万美元,同比去年增长-64.39%
|
| 2024-11-01 |
详情>>
业绩披露：
2025年一季报每股收益-0.01美元,归母净利润-180万美元,同比去年增长-118.37%
|
| 2024-09-27 |
股东大会：
将于2024-11-06召开股东大会
会议内容 ▼▲
- 1.Election of Directors
2.Ratification of the Appointment of PricewaterhouseCoopers LLP as VIAVI’s independent registered public accounting firm for fiscal year 2025
3.Approval, in a Non-Binding Advisory Vote, of the Compensation for Named Executive Officers
|
| 2024-08-16 |
详情>>
业绩披露：
2024年年报每股收益-0.12美元,归母净利润-2580万美元,同比去年增长-201.18%
|
| 2024-08-16 |
详情>>
业绩披露：
2022年年报每股收益0.07美元,归母净利润1550.00万美元,同比去年增长-77.04%
|
| 2024-05-03 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.02美元,归母净利润-410万美元,同比去年增长-116.02%
|
| 2024-02-02 |
详情>>
业绩披露：
2024年中报每股收益0.09美元,归母净利润2050.00万美元,同比去年增长-50%
|
| 2023-11-03 |
详情>>
业绩披露：
2024年一季报每股收益0.04美元,归母净利润980.00万美元,同比去年增长-69.94%
|
| 2023-09-29 |
股东大会：
将于2023-11-08召开股东大会
会议内容 ▼▲
- 1.Election of Directors.
2.Ratification of the Appointment of PricewaterhouseCoopers LLP as VIAVI’s independent registered public accounting firm for fiscal year 2024.
3.Approval, in a Non-Binding Advisory Vote, of the Compensation for Named Executive Officers.
4.Approval, in a Non-Binding Advisory Vote, the Frequency of Stockholder Votes on Executive Compensation.
5.Amendment and Restatement of 2003 Plan
6.Amendment and Restatement of ESPP Plan
|
| 2022-09-29 |
股东大会：
将于2022-11-09召开股东大会
会议内容 ▼▲
- 1.Election of Directors
2.Ratification of the Appointment of PricewaterhouseCoopers LLP as VIAVI’s independent registered public accounting firm for fiscal year 2023
3.Approval, in a Non-Binding Advisory Vote, of the Compensation for Named Executive Officers
|
| 2021-10-01 |
股东大会：
将于2021-11-10召开股东大会
会议内容 ▼▲
- 1.To elect the 8 directors named in this proxy statement;
2.To ratify the appointment of the independent registered public accounting firm for the fiscal year ending July 2, 2022;
3.To approve, on an advisory basis, VIAVI's executive compensation;
4.To consider such other business as may properly come before the meeting.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2020-10-02 |
股东大会：
将于2020-11-11召开股东大会
会议内容 ▼▲
- 1.To elect the 9 directors named in this proxy statement;
2.To ratify the appointment of the independent registered public accounting firm for the fiscal year ending July 3, 2021;
3.To approve, on an advisory basis, VIAVI's executive compensation;
4.To consider such other business as may properly come before the meeting.
|
| 2020-03-16 |
复牌提示：
2020-03-16 09:45:21 停牌，复牌日期 2020-03-16 09:50:21
|
| 2019-10-02 |
股东大会：
将于2019-11-13召开股东大会
会议内容 ▼▲
- 1.To elect the eight nominees named in the proxy statement (the “Proxy Statement”) as directors to serve until the 2020 annual meeting of stockholders (the “2020 Annual Meeting”) and until their respective successors are elected and qualified.
2.To ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending June 27, 2020.
3.To approve, on an advisory basis, the compensation of the Company’s named executive officers for the fiscal year ended June 29, 2019, as set forth in the Proxy Statement.
4.To approve the amendment and restatement of the Company’s Amended and Restated 2003 Equity Incentive Plan.
5.To consider such other business as may properly come before the Annual Meeting and any adjournment or postponement thereof.
|
| 2018-10-02 |
股东大会：
将于2018-11-14召开股东大会
会议内容 ▼▲
- 1.To elect the eight nominees named in the proxy statement (the “Proxy Statement”) as directors to serve until the 2019 annual meeting of stockholders (the “2019 Annual Meeting”) and until their respective successors are elected and qualified.
2.To ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending June 29, 2019.
3.To approve, on an advisory basis, the compensation of the Company’s named executive officers for the fiscal year ended June 30, 2018, as set forth in the Proxy Statement.
4.To consider such other business as may properly come before the Annual Meeting and any adjournment or postponement thereof.
|
| 2017-10-04 |
股东大会：
将于2017-11-15召开股东大会
会议内容 ▼▲
- 1.To elect the eight nominees named in the proxy statement (the “Proxy Statement”) as directors to serve until the 2018 annual meeting of stockholders (the “2018 Annual Meeting”) and until their respective successors are elected and qualified.
2.To ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2018.
3.To approve, on an advisory basis, the compensation of the Company’s named executive officers for the year ended July 1, 2017, as set forth in the Proxy Statement.
4.To approve, on an advisory basis, the frequency of future stockholder votes on executive compensation.
5.To approve the amendment of the Company’s bylaws to provide that the courts located within the state of Delaware will serve as the exclusive forum for the adjudication of certain legal disputes.
6.To approve the amendment and restatement of the Company’s Amended and Restated 2003 Equity Incentive Plan.
7.To approve the amendment and restatement of the Company’s Amended and Restated 1998 Employee Stock Purchase Plan.
8.To consider such other business as may properly come before the Annual Meeting and any adjournment or postponement thereof.
|
| 2016-09-30 |
股东大会：
将于2016-11-15召开股东大会
会议内容 ▼▲
- 1. To elect eight directors to serve until the 2017 annual meeting of stockholders and until their successors are elected and qualified.
2. To ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending July 1, 2017.
3. To consider a non-binding advisory vote on the compensation of our named executive officers.
4. To consider such other business as may properly come before the annual meeting and any adjournment or postponement thereof.
|